News

The latest results of the EAST - AFNET 4  study will be presented at this year's HRS in Boston.

Early Rhythm Control Therapy In Patients With Atrial Fibrillation And Heart Failure (PD Dr. Andreas Rillig)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
10:45am - 10:53am Eastern time / 4:45pm - 4:53pm CEST
More information

Early Rhythm Control for the Treatment of Atrial Fibrillation (Prof. Dr. Paulus Kirchhof)
Live-Stream from the Heart Rhythm Society (HRS 2021), Boston, USA.
Friday, 30 July 2021
1:30pm - 2:30pm Eastern time / 7:30pm - 8:30pm CEST
More information

Hot Topics: Practice Changing Trials in Atrial Fibrillation
EAST - AFNET 4 trial (Prof Dr. Paulus Kirchhof)
Friday, 30 July 2021
4:15pm - 4:27pm Eastern time / 10:15pm - 10:27pm CEST
On site, Exhibit Hall B2 - Booth 1389
More information

The desing paper of the AFFECT-EU project "Digital, risk-based screening for atrial fibrillation in the EU" has recently been published in the European Heart Journal.

The paper can be accessed here.

Our publication of the EAST-AFNET 4 results in the New England Journal of Medicine “Early Rhythm-Control Therapy in Patients with Atrial Fibrillation“ was read over 90.000 (and cited 48) times across all 5 continents. Two “Letters to the Editor” including the answers of the authors were recently released. Please read. 

The Smart in OAC – AFNET 9 study is testing whether unknown atrial fibrillation (AF) can be detected via an app and a monitoring bracelet. It is the objective to detect AF at an early stage using modern technologies. The number of newly detected, previously unknown episodes of atrial fibrillation and the effectivity of the program will be evaluated.

The “Kompetenznetz Vorhofflimmern e.V” (Atrial Fibrillation NETwork – AFNET) is pleased about the enrollment of the 1st patient in Poland and hopes for a good recruitment in all participating countries.

Especially in elderly patients, an infection with Covid-19 often takes a severe course. Therefore, AFNET recommends these patients to get vaccinatied as soon as possible. The protection by the vaccination outweighs possible vaccination risks by far. 

For more information on Covid-19 vaccinations in heart patients, please read the press release of the "Deutsche Gesellschaft für Kardiologie" (German Cardiac Society (DGK)).

Patients on anticoagulation due to atrial fibrillation also benefit from the Covid-19 vaccination. However, these patients should inform the vaccination staff about their medication prior to vaccination in order to minimize any increased risk of bleeding.

For detailed guidance on Covid-19 vaccinations in patients treated with anticoagulants, please read the press release of the "Deutsche Herzstiftung" (German Heart Foundation (Deutsche Herzstiftung)).